Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
7.35
-0.33 (-4.30%)
At close: Aug 18, 2025, 3:59 PM
7.33
-0.26%
After-hours: Aug 18, 2025, 07:31 PM EDT
-4.30% (1D)
| Bid | 7.32 |
| Market Cap | 1.19B |
| Revenue (ttm) | 246.03M |
| Net Income (ttm) | -32M |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -36.75 |
| Forward PE | 56.83 |
| Analyst | Buy |
| Ask | 7.4 |
| Volume | 2,463,382 |
| Avg. Volume (20D) | 2,467,045 |
| Open | 7.62 |
| Previous Close | 7.68 |
| Day's Range | 7.34 - 7.79 |
| 52-Week Range | 2.48 - 7.79 |
| Beta | 0.86 |
About XERS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol XERS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for XERS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Xeris Biopharma Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+20.22%
Xeris Biopharma Holdings shares are trading higher...
Unlock content with
Pro Subscription
2 months ago
-7.92%
Xeris Biopharma Holdings shares are trading lower. The company released Its strategy for long-term growth and value creation at 2025 analyst & investor day.
